DINAK-002

N/A

Report date: 2024/09/02 15:39:39

Base Information

Drug NameDINAK-002
Drug Alias NameDINAK-002
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transference
TargetsUpdating
Therapy Area/IndicationsPolycystic Kidney, Autosomal Dominant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDinaqor AG
China Registration ClassN/A

Develop Information

Active CompaniesDinaqor AG
Inactive CompaniesN/A
Active IndicationsPolycystic Kidney, Autosomal Dominant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A